An observational study in Stroke, sponsored by University Hospital, Ghent. Recruiting at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-03.
Sponsored by University Hospital, Ghent · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies in Stroke by University Hospital, Ghent — 9 open to participants now, 9 under way, none of them phase 3. Stroke · University Hospital, Ghent.
Among the 18 studies in Stroke by University Hospital, Ghent, this one is one of 2 that started in 2026, is one of 5 observational ones, and was the 17th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →9 of the 18 studies in Stroke by University Hospital, Ghent are open now, in 1 country. Recruiting first, the newest first:
University Hospital, Ghent · Sites in Belgium
Ages 18+ · Healthy volunteers
University Hospital, Ghent · Sites in Belgium
University Hospital, Ghent · Sites in Belgium
Ages 18+
University Hospital, Ghent · Sites in Belgium
Ages 18–70 · Healthy volunteers
University Hospital, Ghent · Sites in Belgium
Ages 18–70
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 2 started in 2026.
This study's planned enrollment of 20 is below the median of 150 across 1,971 observational studies indexed under Stroke.
Median enrollment 30 across the 13 interventional studies, 260 across the 5 observational. Of the 8 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University Hospital, Ghent is the lead sponsor of 689 studies on the registry; 157 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.
4 of the studies in Stroke by University Hospital, Ghent that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06442579University Hospital, GhentThe Influence of Cortical Lateralization on Selective Motor Control of the Arm Swing During Independent Walking After Stroke. | 2026-12-30 |
| NCT07059351University Hospital, GhentOral Status as Predictors of Stroke-Associated Pneumonia and Swallowing Recovery in Patients With Post-Stroke Dysphagia | 2027-07-01 |
| NCT06847217University Hospital, GhentEffect of Applying Oral Hygiene Care on Swallowing in Stroke Patients With Oropharyngeal Dysphagia | 2027-10-01 |
| NCT07387328University Hospital, GhentValidation of New sEMG Electrode Placement Guidelines for the Triceps Surae in Post-stroke Individuals | 2027-10-31 |
Add all 4 to your calendar (.ics) → With an account.
Among the 18 studies in Stroke by University Hospital, Ghent, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Background and rationale:
Surface electromyography (EMG) is a non-invasive method to measure muscle activity, among others in people after a stroke during gait analysis. Measurement quality is strongly influenced by electrode placement. However, the commonly used SENIAM guidelines do not take individual variations in muscle morphology into account, which can lead to inaccurate measurements. In previous research demonstrated that the standard placement on the triceps surae (medial and lateral gastrocnemius and soleus) was suboptimal at the group level and sometimes even problematic at the individual level. Therefore, new placement guidelines (EPICA guidelines, Electrode Placement for Individual Calf Anatomy) were developed, which are currently being tested in healthy individuals.
Method:
In this project aims to validate these newly developed guidelines in people after a stroke who exhibit atrophy of their calf muscles. For each participant, electrode positions on the hemiplegic side will be determined according to our guidelines while the participant is lying prone. Circular stickers will be used instead of actual EMG electrodes and will be placed according to the EPICA guidelines as well as according to the SENIAM guidelines. Subsequently, the muscle borders of the triceps surae will be identified on the participant's leg using 2D ultrasound. Afterwards, the distance between the electrodes and the surrounding muscle borders will be measured to map electrode placement on the muscle in order to validate the guidelines.
In the second part of this study, 3D ultrasound recordings will be made of the soleus, medial gastrocnemius, and lateral gastrocnemius with the electrodes (stickers) on these muscles, so that during image processing, electrode positions can be visualized relative to the entire muscle, including along the depth axis. In addition, participants who can safely walk without an ankle-foot orthosis will be asked to walk a maximum of five times ten meters. Additionally, an ultrasound probe will be attached to the leg to investigate how the electrode position relates to the muscle-tendon junction during movement. Subsequently, actual electrodes will also be placed to record muscle activity during walking and heel raises.
Furthermore, all participants will be asked to do a heel raise to activate the calf muscles. As such, the quality of the EMG signals will be evaluated. Other measurements will included: Fugl-Meyer Assessment of the lower limb, measure passive ankle range of motion with a goniometer, and measure lower leg length with a tape measure. These will be used as descriptive parameters of our study population.
Patients will be asked on a voluntary basis to participate in a second, short measurement approximately two weeks after the first session. During this measurement, electrode placement will again be performed according to the EPICA guidelines. 3D ultrasound will again be used to calculate the distances between the electrodes and the muscle borders. This second measurement is necessary to investigate the test-retest reliability of the EPICA guidelines in people after a stroke.
Persons after stroke.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Electrode-muscle boundary distances for EPICA-electrodes
These distances, measured with a tape measure, will be obtained between the EPICA electrode positions and the muscle boundaries as visualized using 2D ultrasound.
Time frame: At study enrollment and a second time at least two weeks later.
Electrode-muscle boundary distances for SENIAM-electrodes
These distances, measured with a tape measure, will be obtained between the SENIAM electrode positions and the muscle boundaries as visualized using 2D ultrasound.
Time frame: At study enrollment.
Triceps surae muscle geometry
Triceps surae muscle geometry will be measured using 3D freehand ultrasound.
Time frame: At study enrollment.
Muscle-tendon junction displacement of the lateral gastrocnemius during walking.
This will be measured with dynamic 2D ultrasound.
Time frame: At study enrollment.
Muscle-tendon junction displacement of the lateral gastrocnemius during a heel raise.
This will be measured using dynamic 2D ultrasound.
Time frame: At study enrollment.
Muscle-tendon junction displacement of the medial gastrocnemius during walking.
This will be measured using dynamic 2D ultrasound.
Time frame: At study enrollment.
Muscle-tendon junction displacement of the medial gastrocnemius during a heel raise.
This will be measured using dynamic 2D ultrasound.
Time frame: At study enrollment.
Quality features of the surface electromyography signals obtained from the EPICA electrodes during the dynamic tasks.
Time frame: At study enrollment.
Quality features of the surface electromyography signals obtained from the SENIAM electrodes during the dynamic tasks.
Time frame: At study enrollment.
Fugl-Meyer Assessment score of the paretic lower limb.
Minumum score is 0 and maximum score is 34. A higher score involves a less impaired hemiparetic leg.
Time frame: At study enrollment.
Passive ankle range of motion.
This will be measured using a manual goniometer.
Time frame: At study enrollment.
Surface electromyography amplitude during the dynamic tasks.
Time frame: At study enrollment.
Surface electromyography timing during the dynamic tasks.
Time frame: At study enrollment.
Spatiotemporal parameters derived from inertial measurement units
Time frame: At study enrollment.
Plan to share: No
Started Apr 2026 (actual). Primary completion is estimated for Oct 2027, 18 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.